(IXJ) iShares Global Healthcare - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642873255 • Health
IXJ: Healthcare, Medicine, Equipment, Services, Biotech, Pharmaceuticals
The iShares Global Healthcare ETF (IXJ) is a straightforward way to gain exposure to the global healthcare sector. It primarily invests at least 80% of its assets in securities that replicate the performance of its underlying index, which tracks companies deemed critical to the healthcare industry worldwide. The fund also allocates up to 20% of its assets to derivatives like futures, options, and swap contracts, as well as cash and cash equivalents, to help manage risk or enhance returns.
The underlying index focuses on companies that the index provider identifies as key players in the healthcare sector, ensuring the fund captures a broad range of industry participants. This includes pharmaceutical firms, biotechnology companies, medical device manufacturers, and healthcare service providers. The fund is domiciled in the United States and is listed on the NYSE ARCA under the ticker symbol IXJ.
With an assets under management (AUM) of approximately $3.85 billion, IXJ is a substantial fund that offers diversification across the global healthcare market. It provides investors with a cost-effective way to access a portfolio of healthcare companies without the need to pick individual stocks. For fund managers, this ETF can serve as a core holding or a tactical allocation within a broader portfolio.
Additional Sources for IXJ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IXJ ETF Overview
Market Cap in USD | 4,031m |
Category | Health |
TER | 0.42% |
IPO / Inception | 2001-11-13 |
IXJ ETF Ratings
Growth 5y | 58.9% |
Fundamental | - |
Dividend | 52.3% |
Rel. Strength Industry | -8.64 |
Analysts | - |
Fair Price Momentum | 90.75 USD |
Fair Price DCF | - |
IXJ Dividends
Dividend Yield 12m | 1.41% |
Yield on Cost 5y | 2.50% |
Annual Growth 5y | 5.79% |
Payout Consistency | 92.2% |
IXJ Growth Ratios
Growth Correlation 3m | 81.3% |
Growth Correlation 12m | 3.1% |
Growth Correlation 5y | 85.7% |
CAGR 5y | 11.86% |
CAGR/Max DD 5y | 0.68 |
Sharpe Ratio 12m | -0.13 |
Alpha | -6.96 |
Beta | 0.41 |
Volatility | 12.95% |
Current Volume | 135.5k |
Average Volume 20d | 168.6k |
As of March 14, 2025, the stock is trading at USD 90.36 with a total of 135,528 shares traded.
Over the past week, the price has changed by -3.50%, over one month by -1.24%, over three months by +2.32% and over the past year by -1.11%.
Partly, yes. Based on ValueRay Analyses, iShares Global Healthcare (NYSE ARCA:IXJ) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.89 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IXJ as of March 2025 is 90.75. This means that IXJ is currently overvalued and has a potential downside of 0.43%.
iShares Global Healthcare has no consensus analysts rating.
According to ValueRays Forecast Model, IXJ iShares Global Healthcare will be worth about 99 in March 2026. The stock is currently trading at 90.36. This means that the stock has a potential upside of +9.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 99 | 9.5% |